The Effects of Different Immunosuppressants on Chronic Allograft Nephropathy by Affecting the Transforming Growth Factor-β and Smads Signal Pathways

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2154-2157

  Gao, R ^a   Lu, Y ^a   Xin, Y P ^a   Zhang, X H ^a   Wang, J ^a   Li, Y P ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; HEPARIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOLOGY; ISCHEMIA; ISOTRANSPLANTATION; MALE; NEPHROSCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846062366     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.006     Document Type: Article

References (9)

1. Tullius S.G., and Tilney N.L. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59 (1995) 313
2. Shehata M., Cope G., Johnson T., et al. Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int 48 (1995) 1487
3. Wang T., Donahoe P.K., and Zervos A.S. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP12. Science 265 (1994) 674
4. Firemann S., Feuring E., Padberg W., et al. Improvement of nephrotoxicity, hypertension, and lipid metabolism after version of kidney transplant recipient from cyclosporine to tacrolimus. Transplant Proc 30 (1998) 1241
5. Hirofumi I., Kiyoshi T., Seiji U., et al. Smad protein and TGF-β signaling in vascular smooth muscle cells. Int J Mol Med 11 (2003) 645
6. Gregoor P.J.H., deSevaux R.G.L., Ligtenberg G., et al. A prospective, randomized study of withdrawal of cyclosporine or prednisone in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone: 18 months follow up data. Am J Transplant 1 suppl 1 (2001) S246
7. Abramowicz D., and Wissing K.M. Nephrotoxicity of calcineurininhibitors: new therapeutic approaches. Transplant Proc 32 suppl 1A (2000) S3
8. Sharma V.K., Li B., Ding K., et al. Chronic allograft nephropathy: a TGF-β1 centered fibrogenic cytokine paradigm for disease progression. Graft 1 suppl II (1998) 25
9. Zimmerman C.M., and Padgett R.W. Transforming growth factor beta signaling mediators and modulators. Gene 249 (2000) 17